FDA released new draft guidance to solicit public comment on proposals for broader safety evaluations of new therapies to treat type 2 diabetes that look beyond ischemic cardiovascular disease and the inclusion of a broader scope of human subjects.
from FDA Press Releases RSS Feed https://ift.tt/38ykkj9
via IFTTT
No comments:
Post a Comment